Better Therapeutics, Inc. (BTTX)
BTTX Stock Price Chart
Explore Better Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze BTTX price movements and trends.
BTTX Company Profile
Discover essential business fundamentals and corporate details for Better Therapeutics, Inc. (BTTX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Mar 2021
Employees
54.00
Website
https://www.bettertx.comCEO
David P. Perry
Description
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.
BTTX Financial Timeline
Browse a chronological timeline of Better Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 4 Jun 2025
Earnings released on 29 May 2025
Earnings released on 28 Mar 2025
Earnings released on 27 Dec 2024
Earnings released on 25 Sept 2024
Earnings released on 9 May 2024
Earnings released on 12 Mar 2024
Earnings released on 9 Nov 2023
EPS came in at -$0.15 surpassing the estimated -$0.19 by +21.05%.
Earnings released on 9 Aug 2023
EPS came in at -$0.24 surpassing the estimated -$0.39 by +38.46%.
Earnings released on 30 Mar 2023
EPS came in at -$0.37 surpassing the estimated -$0.53 by +30.19%.
Earnings released on 27 Mar 2023
EPS came in at -$0.71 falling short of the estimated -$0.51 by -39.22%.
Earnings released on 14 Nov 2022
EPS came in at -$0.48 surpassing the estimated -$0.50 by +4.00%.
Earnings released on 11 Aug 2022
EPS came in at -$0.42 surpassing the estimated -$0.47 by +10.64%.
Earnings released on 13 May 2022
EPS came in at -$0.41 falling short of the estimated -$0.30 by -36.67%.
Earnings released on 28 Mar 2022
EPS came in at -$0.71 falling short of the estimated -$0.46 by -54.35%, while revenue for the quarter reached $284.00K .
Earnings released on 23 Nov 2021
EPS came in at -$0.03 surpassing the estimated -$1.66 by +98.19%.
Earnings released on 20 Aug 2021
EPS came in at -$0.37 .
Earnings released on 24 May 2021
EPS came in at -$0.23 .
Earnings released on 31 Mar 2021
EPS came in at -$0.09 , while revenue for the quarter reached $1.04K .
Earnings released on 30 Sept 2020
EPS came in at -$0.50 , while revenue for the quarter reached $1.00 .
BTTX Stock Performance
Access detailed BTTX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.